Maxnerva Technology Services Limited (HKG:1037)
0.6200
-0.0100 (-1.59%)
Jun 3, 2026, 1:22 PM HKT
HKG:1037 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 707.58 | 558.94 | 677.88 | 832.46 | 596.35 | |
Revenue Growth (YoY) | 26.59% | -17.55% | -18.57% | 39.59% | 13.93% |
Cost of Revenue | 602.02 | 471 | 581.1 | 705.31 | 482.23 |
Gross Profit | 105.56 | 87.94 | 96.78 | 127.15 | 114.12 |
Selling, General & Admin | 82.7 | 82.45 | 91 | 90.72 | 72.78 |
Research & Development | 0.89 | 3.49 | 9.02 | 10.14 | 16.99 |
Other Operating Expenses | -0.84 | -2.76 | -2.52 | -2.71 | -3.96 |
Operating Expenses | 85.84 | 82.41 | 95.98 | 101.5 | 99.24 |
Operating Income | 19.72 | 5.53 | 0.8 | 25.64 | 14.88 |
Interest Expense | -0.25 | -0.27 | -0.21 | -0.51 | -0.85 |
Interest & Investment Income | 0.5 | 2.44 | 1.84 | 1.92 | 2.31 |
Earnings From Equity Investments | 0.05 | -0.02 | -4.73 | -3.32 | - |
Currency Exchange Gain (Loss) | -3.34 | 2.54 | -0.21 | 4.74 | 2.8 |
EBT Excluding Unusual Items | 16.68 | 10.22 | -2.51 | 28.47 | 19.15 |
Gain (Loss) on Sale of Investments | -28.34 | -17.09 | -1.06 | 2.02 | 18.46 |
Gain (Loss) on Sale of Assets | 0.01 | 0.13 | - | - | -0 |
Asset Writedown | - | -2.33 | -10.63 | - | - |
Pretax Income | -11.66 | -9.06 | -14.2 | 30.48 | 37.61 |
Income Tax Expense | 2.89 | 3.38 | 2.64 | 2.65 | 3.35 |
Earnings From Continuing Operations | -14.55 | -12.44 | -16.83 | 27.83 | 34.26 |
Net Income | -14.55 | -12.44 | -16.83 | 27.83 | 34.26 |
Net Income to Common | -14.55 | -12.44 | -16.83 | 27.83 | 34.26 |
Net Income Growth | - | - | - | -18.77% | 134.12% |
Shares Outstanding (Basic) | 702 | 702 | 702 | 702 | 691 |
Shares Outstanding (Diluted) | 702 | 702 | 702 | 702 | 691 |
Shares Change (YoY) | 0.13% | - | - | 1.48% | 5.57% |
EPS (Basic) | -0.02 | -0.02 | -0.02 | 0.04 | 0.05 |
EPS (Diluted) | -0.02 | -0.02 | -0.02 | 0.04 | 0.05 |
EPS Growth | - | - | - | -19.96% | 122.24% |
Free Cash Flow | -68.93 | -1.34 | 31.25 | 20.32 | 13 |
Free Cash Flow Per Share | -0.10 | -0.00 | 0.04 | 0.03 | 0.02 |
Gross Margin | 14.92% | 15.73% | 14.28% | 15.27% | 19.14% |
Operating Margin | 2.79% | 0.99% | 0.12% | 3.08% | 2.50% |
Profit Margin | -2.06% | -2.23% | -2.48% | 3.34% | 5.75% |
Free Cash Flow Margin | -9.74% | -0.24% | 4.61% | 2.44% | 2.18% |
EBITDA | 24.91 | 9.9 | 6.88 | 32.82 | 22.84 |
EBITDA Margin | 3.52% | 1.77% | 1.01% | 3.94% | 3.83% |
D&A For EBITDA | 5.2 | 4.37 | 6.08 | 7.17 | 7.96 |
EBIT | 19.72 | 5.53 | 0.8 | 25.64 | 14.88 |
EBIT Margin | 2.79% | 0.99% | 0.12% | 3.08% | 2.50% |
Effective Tax Rate | - | - | - | 8.70% | 8.90% |
Advertising Expenses | 1.63 | 0.8 | 1.23 | 1.72 | 0.46 |